SlideShare a Scribd company logo
CytosolCytosol
HepatocyteHepatocyte
ApoB
DegradationDegradation
5'
3'
ApoB mRNAApoB mRNA
TranslationTranslation
ERMembraneERMembrane
Insulin
IRS1/IRS2
IR
InsulinSignalingPathway
InsulinSignalingPathway
Plasm
a
Plasm
a
VLDLVLDL
Insulin Signaling & VLDL OverproductionInsulin Signaling & VLDL Overproduction
in Insulin Resistancein Insulin Resistance
PI3-Kinase
VLDL AssemblyVLDL Assembly
PIP3/Phosphorylation CascadePIP3/Phosphorylation Cascade
Akt/PKBAkt/PKB
PTP-1BPTP-1B
3'
D
InsulinReceptorproteinMass
(scanningunits/mgproteinx10-3
)
Control Fructose-fed
Control Fructose-fed
0
50
100
150
200
250
IRS-1ProteinMass
(scanningunits/mgproteinx10-3
)
Control Fructose-fed
Control Fructose-fed
0
40
80
120
E F Control Fructose-fed
0
20
40
60
80
100
120
Control Fructose-fed
IRS-2Mass(percentofcontrol)
C
PhosphorylatedIRS-2
(relativetobasallevelofcontrol)
0
20
40
60
80
100
120
140
160
180
_
+
_
+
Insulin
+ + + +Insulin _ _ _ _
Control Fructose-fed
Control
Fructose-fed
Impaired Hepatic Tyrosine Phosphorylation of
Insulin Receptor, IRS-1, and IRS-2
in Fructose-Fed Hamsters
A
PhosphorylatedInsulinReceptorMass
(scanningunits/mgproteinx10-3
)
Control Fructose-fed
0
100
200
300
400
500
600
_
+
_
+
Insulin
+ + + +Insulin _ _ _ _
*
B
_
+
_
+
Insulin
PhosphorylatedIRS-1
(scanningunits/mgproteinx10-3
)
Control Fructose-fed
0
20
40
60
80
100
120
Control
Fructose-fed
+ + + +Insulin _ _ _ _
P= 0.04
P= 0.009
P= 0.02
P= 0.03
P= 0.029
*
*
B
0
50
100
150
200
PTP-1BMass
(percentofcontrol)
Control Fructose-fed
Control Fructose-fed
C
0
100
200
300
PTP-1BActivity
(percentofcontrol)
Control Fructose-fed
A
0
20
40
60
80
100
120
PI3-KinaseActivity
(percentofcontrol)
Control Fructose-fed
* **
***
D
+ + + +Insulin
0
20
40
60
80
100
120
140
Insulin-InducedAktSerine
Phosphorylation(%ofcontrol)
Control Fructose-fed
Insulin
_
+ _
+
E
Insulin
Insulin-InducedAktThreonine
Phosphorylation(%ofcontrol)
Control Fructose-fed
0
20
40
60
80
100
120
_
+
_
+
+ + + +
Insulin
F Control Fructose-fed
20
40
60
80
100
120
140
160
AktProteinMass
(percentofcontrol)
0
Control Fructose-fed
****
***
*
Evidence for Reduced PI-3 Kinase
Activity, Reduced Akt Phosphorylation,
& Enhanced PTP-1B Mass & Activity
0
20
40
60
80
100
120
0 20 40 60 80
Vanadate (µM)
RecoveredCellularApoB
(relativetountreated)
B
0
20
40
60
80
100
120
0 20 40 60 80
Vanadate (µM)
RecoveredLabeledMediaApoB
(relativetountreated)
C
Vanadate (µM)
RecoveredTotalApoB
(relativetountreated)
0
20
40
60
80
100
120
0 20 40 60 80
D
Vanadate (µM) 0 10 40 80
IR-pY
0
100
200
300
400
500
600
0 20 40 60 80
Vanadate (µM)
InsulinReceptorPhosphorylation
(relativetountreated)
A
0 10 20 40 80Vanadate (µM)
Cellular ApoB
Secreted ApoB
E
Inhibition of Cellular Phosphatase Activity with Vanadate
Enhances Insulin Signaling and Reduces ApoB Secretion
IR-IR-ppYY
Cellular ApoBCellular ApoB
ApoB StabilityApoB Stability
ApoB SecretionApoB Secretion

More Related Content

Viewers also liked

Moreno mort meeting
Moreno mort meetingMoreno mort meeting
Nih ppg 9-02
Nih ppg 9-02Nih ppg 9-02
096 mri imaging of atherosclerosis using spio
096 mri imaging of atherosclerosis using spio096 mri imaging of atherosclerosis using spio
096 mri imaging of atherosclerosis using spio
Society for Heart Attack Prevention and Eradication
 
Old vulnerable patient slides with movies
Old vulnerable patient slides with moviesOld vulnerable patient slides with movies
Old vulnerable patient slides with movies
Society for Heart Attack Prevention and Eradication
 
Molecular genetics
Molecular geneticsMolecular genetics
Out of hospital
Out of hospitalOut of hospital
Virmani
VirmaniVirmani
081 carotid artery plaque
081 carotid artery plaque081 carotid artery plaque
092 il18 and il18 bp in atherosclerosis
092 il18 and il18 bp in atherosclerosis092 il18 and il18 bp in atherosclerosis
092 il18 and il18 bp in atherosclerosis
Society for Heart Attack Prevention and Eradication
 
087 mri of atherosclerotic plaque in apo e ko mice
087 mri of atherosclerotic plaque in apo e ko  mice087 mri of atherosclerotic plaque in apo e ko  mice
087 mri of atherosclerotic plaque in apo e ko mice
Society for Heart Attack Prevention and Eradication
 
Nir catheter final
Nir catheter finalNir catheter final
Vp 2002 talk show copy galis
Vp 2002 talk show copy galisVp 2002 talk show copy galis
Mri system block diagram
Mri system block diagramMri system block diagram
Near infrared spectroscopy 2
Near infrared spectroscopy 2Near infrared spectroscopy 2

Viewers also liked (14)

Moreno mort meeting
Moreno mort meetingMoreno mort meeting
Moreno mort meeting
 
Nih ppg 9-02
Nih ppg 9-02Nih ppg 9-02
Nih ppg 9-02
 
096 mri imaging of atherosclerosis using spio
096 mri imaging of atherosclerosis using spio096 mri imaging of atherosclerosis using spio
096 mri imaging of atherosclerosis using spio
 
Old vulnerable patient slides with movies
Old vulnerable patient slides with moviesOld vulnerable patient slides with movies
Old vulnerable patient slides with movies
 
Molecular genetics
Molecular geneticsMolecular genetics
Molecular genetics
 
Out of hospital
Out of hospitalOut of hospital
Out of hospital
 
Virmani
VirmaniVirmani
Virmani
 
081 carotid artery plaque
081 carotid artery plaque081 carotid artery plaque
081 carotid artery plaque
 
092 il18 and il18 bp in atherosclerosis
092 il18 and il18 bp in atherosclerosis092 il18 and il18 bp in atherosclerosis
092 il18 and il18 bp in atherosclerosis
 
087 mri of atherosclerotic plaque in apo e ko mice
087 mri of atherosclerotic plaque in apo e ko  mice087 mri of atherosclerotic plaque in apo e ko  mice
087 mri of atherosclerotic plaque in apo e ko mice
 
Nir catheter final
Nir catheter finalNir catheter final
Nir catheter final
 
Vp 2002 talk show copy galis
Vp 2002 talk show copy galisVp 2002 talk show copy galis
Vp 2002 talk show copy galis
 
Mri system block diagram
Mri system block diagramMri system block diagram
Mri system block diagram
 
Near infrared spectroscopy 2
Near infrared spectroscopy 2Near infrared spectroscopy 2
Near infrared spectroscopy 2
 

Similar to Adeli 21 24

Adeli 9 20
Adeli 9 20Adeli 9 20
195 hepatic synthesis and secretion of vldl
195 hepatic synthesis and secretion of vldl195 hepatic synthesis and secretion of vldl
195 hepatic synthesis and secretion of vldl
Society for Heart Attack Prevention and Eradication
 
Slides 9 20
Slides 9 20Slides 9 20
195 hepatic synthesis and secretion of vldl
195 hepatic synthesis and secretion of vldl195 hepatic synthesis and secretion of vldl
195 hepatic synthesis and secretion of vldl
SHAPE Society
 
Slides920
Slides920Slides920
Slides2528
Slides2528Slides2528
Slides 25 28
Slides 25 28Slides 25 28
183 postulated mechanisms of insulin resistance
183 postulated mechanisms of insulin resistance183 postulated mechanisms of insulin resistance
183 postulated mechanisms of insulin resistance
SHAPE Society
 
Tapboost pegs boston slide ver 2015 06-23
Tapboost   pegs boston slide ver 2015 06-23 Tapboost   pegs boston slide ver 2015 06-23
Tapboost pegs boston slide ver 2015 06-23
nanalaw
 
PEGS Boston slide strategia
PEGS Boston slide strategiaPEGS Boston slide strategia
PEGS Boston slide strategia
Paul Wengender
 
6 RTK signaling MAPK Akt.pdfCell signaling presentation
6 RTK signaling MAPK Akt.pdfCell signaling presentation6 RTK signaling MAPK Akt.pdfCell signaling presentation
6 RTK signaling MAPK Akt.pdfCell signaling presentation
vincentlangat14
 
Discriminating Facts from Artefacts in the Secreted Ly-6 Protein Family
Discriminating Facts from Artefacts in the Secreted Ly-6 Protein FamilyDiscriminating Facts from Artefacts in the Secreted Ly-6 Protein Family
Discriminating Facts from Artefacts in the Secreted Ly-6 Protein Family
Chris Southan
 
Animal biotech
Animal biotechAnimal biotech
Animal biotech
melvin1992
 
Pathways of intracellular signal transduction
Pathways of intracellular signal transductionPathways of intracellular signal transduction
Pathways of intracellular signal transduction
MohamedEramHosen
 
CDD 2016
CDD 2016CDD 2016

Similar to Adeli 21 24 (15)

Adeli 9 20
Adeli 9 20Adeli 9 20
Adeli 9 20
 
195 hepatic synthesis and secretion of vldl
195 hepatic synthesis and secretion of vldl195 hepatic synthesis and secretion of vldl
195 hepatic synthesis and secretion of vldl
 
Slides 9 20
Slides 9 20Slides 9 20
Slides 9 20
 
195 hepatic synthesis and secretion of vldl
195 hepatic synthesis and secretion of vldl195 hepatic synthesis and secretion of vldl
195 hepatic synthesis and secretion of vldl
 
Slides920
Slides920Slides920
Slides920
 
Slides2528
Slides2528Slides2528
Slides2528
 
Slides 25 28
Slides 25 28Slides 25 28
Slides 25 28
 
183 postulated mechanisms of insulin resistance
183 postulated mechanisms of insulin resistance183 postulated mechanisms of insulin resistance
183 postulated mechanisms of insulin resistance
 
Tapboost pegs boston slide ver 2015 06-23
Tapboost   pegs boston slide ver 2015 06-23 Tapboost   pegs boston slide ver 2015 06-23
Tapboost pegs boston slide ver 2015 06-23
 
PEGS Boston slide strategia
PEGS Boston slide strategiaPEGS Boston slide strategia
PEGS Boston slide strategia
 
6 RTK signaling MAPK Akt.pdfCell signaling presentation
6 RTK signaling MAPK Akt.pdfCell signaling presentation6 RTK signaling MAPK Akt.pdfCell signaling presentation
6 RTK signaling MAPK Akt.pdfCell signaling presentation
 
Discriminating Facts from Artefacts in the Secreted Ly-6 Protein Family
Discriminating Facts from Artefacts in the Secreted Ly-6 Protein FamilyDiscriminating Facts from Artefacts in the Secreted Ly-6 Protein Family
Discriminating Facts from Artefacts in the Secreted Ly-6 Protein Family
 
Animal biotech
Animal biotechAnimal biotech
Animal biotech
 
Pathways of intracellular signal transduction
Pathways of intracellular signal transductionPathways of intracellular signal transduction
Pathways of intracellular signal transduction
 
CDD 2016
CDD 2016CDD 2016
CDD 2016
 

More from Society for Heart Attack Prevention and Eradication

AHA SHAPE Symposium 2017 Dr. Naghavi Presentation
AHA SHAPE Symposium 2017 Dr. Naghavi PresentationAHA SHAPE Symposium 2017 Dr. Naghavi Presentation
AHA SHAPE Symposium 2017 Dr. Naghavi Presentation
Society for Heart Attack Prevention and Eradication
 
AHA SHAPE Symposium 2017 Dr. Kloner Presentation
AHA SHAPE Symposium 2017 Dr. Kloner PresentationAHA SHAPE Symposium 2017 Dr. Kloner Presentation
AHA SHAPE Symposium 2017 Dr. Kloner Presentation
Society for Heart Attack Prevention and Eradication
 
AHA SHAPE Symposium 2017 Dr. Greenland Presentation
AHA SHAPE Symposium 2017 Dr. Greenland PresentationAHA SHAPE Symposium 2017 Dr. Greenland Presentation
AHA SHAPE Symposium 2017 Dr. Greenland Presentation
Society for Heart Attack Prevention and Eradication
 
AHA SHAPE Symposium 2017 Dr. Yen Presentation
AHA SHAPE Symposium 2017 Dr. Yen PresentationAHA SHAPE Symposium 2017 Dr. Yen Presentation
AHA SHAPE Symposium 2017 Dr. Yen Presentation
Society for Heart Attack Prevention and Eradication
 
AHA SHAPE Symposium 2017 Dr. Slomka Presentation
AHA SHAPE Symposium 2017 Dr. Slomka PresentationAHA SHAPE Symposium 2017 Dr. Slomka Presentation
AHA SHAPE Symposium 2017 Dr. Slomka Presentation
Society for Heart Attack Prevention and Eradication
 
Vu lplaque1 pasterkamp
Vu lplaque1 pasterkampVu lplaque1 pasterkamp
Vulnerable plaque vulnerable patient
Vulnerable plaque vulnerable patientVulnerable plaque vulnerable patient
Vulnerable plaque vulnerable patient
Society for Heart Attack Prevention and Eradication
 
Vulnerable plaque overview
Vulnerable plaque overviewVulnerable plaque overview
Vulnerable patient talk in poland
Vulnerable patient talk in polandVulnerable patient talk in poland
Vulnerable patient talk in poland
Society for Heart Attack Prevention and Eradication
 
Vulnerable patient slides without movies
Vulnerable patient slides without moviesVulnerable patient slides without movies
Vulnerable patient slides without movies
Society for Heart Attack Prevention and Eradication
 
Vulnerable patient mar 04
Vulnerable patient mar 04Vulnerable patient mar 04
Vulnerable (thrombogenic blood
Vulnerable (thrombogenic bloodVulnerable (thrombogenic blood
Vuln shape aha 2005
Vuln shape aha 2005Vuln shape aha 2005
Vuln plaque poster burke
Vuln plaque poster burkeVuln plaque poster burke
Vp watch editorial_slide 25short-
Vp watch editorial_slide 25short-Vp watch editorial_slide 25short-
Vp watch editorial_slide 25short-
Society for Heart Attack Prevention and Eradication
 
Vp watch editorial_slide25
Vp watch editorial_slide25Vp watch editorial_slide25
Vp watch editorial_slide25short-
Vp watch editorial_slide25short-Vp watch editorial_slide25short-
Vp watch editorial_slide25short-
Society for Heart Attack Prevention and Eradication
 
Vp watch2002
Vp watch2002Vp watch2002
Vp symposium31602
Vp symposium31602Vp symposium31602
Vpschoenhagen
VpschoenhagenVpschoenhagen

More from Society for Heart Attack Prevention and Eradication (20)

AHA SHAPE Symposium 2017 Dr. Naghavi Presentation
AHA SHAPE Symposium 2017 Dr. Naghavi PresentationAHA SHAPE Symposium 2017 Dr. Naghavi Presentation
AHA SHAPE Symposium 2017 Dr. Naghavi Presentation
 
AHA SHAPE Symposium 2017 Dr. Kloner Presentation
AHA SHAPE Symposium 2017 Dr. Kloner PresentationAHA SHAPE Symposium 2017 Dr. Kloner Presentation
AHA SHAPE Symposium 2017 Dr. Kloner Presentation
 
AHA SHAPE Symposium 2017 Dr. Greenland Presentation
AHA SHAPE Symposium 2017 Dr. Greenland PresentationAHA SHAPE Symposium 2017 Dr. Greenland Presentation
AHA SHAPE Symposium 2017 Dr. Greenland Presentation
 
AHA SHAPE Symposium 2017 Dr. Yen Presentation
AHA SHAPE Symposium 2017 Dr. Yen PresentationAHA SHAPE Symposium 2017 Dr. Yen Presentation
AHA SHAPE Symposium 2017 Dr. Yen Presentation
 
AHA SHAPE Symposium 2017 Dr. Slomka Presentation
AHA SHAPE Symposium 2017 Dr. Slomka PresentationAHA SHAPE Symposium 2017 Dr. Slomka Presentation
AHA SHAPE Symposium 2017 Dr. Slomka Presentation
 
Vu lplaque1 pasterkamp
Vu lplaque1 pasterkampVu lplaque1 pasterkamp
Vu lplaque1 pasterkamp
 
Vulnerable plaque vulnerable patient
Vulnerable plaque vulnerable patientVulnerable plaque vulnerable patient
Vulnerable plaque vulnerable patient
 
Vulnerable plaque overview
Vulnerable plaque overviewVulnerable plaque overview
Vulnerable plaque overview
 
Vulnerable patient talk in poland
Vulnerable patient talk in polandVulnerable patient talk in poland
Vulnerable patient talk in poland
 
Vulnerable patient slides without movies
Vulnerable patient slides without moviesVulnerable patient slides without movies
Vulnerable patient slides without movies
 
Vulnerable patient mar 04
Vulnerable patient mar 04Vulnerable patient mar 04
Vulnerable patient mar 04
 
Vulnerable (thrombogenic blood
Vulnerable (thrombogenic bloodVulnerable (thrombogenic blood
Vulnerable (thrombogenic blood
 
Vuln shape aha 2005
Vuln shape aha 2005Vuln shape aha 2005
Vuln shape aha 2005
 
Vuln plaque poster burke
Vuln plaque poster burkeVuln plaque poster burke
Vuln plaque poster burke
 
Vp watch editorial_slide 25short-
Vp watch editorial_slide 25short-Vp watch editorial_slide 25short-
Vp watch editorial_slide 25short-
 
Vp watch editorial_slide25
Vp watch editorial_slide25Vp watch editorial_slide25
Vp watch editorial_slide25
 
Vp watch editorial_slide25short-
Vp watch editorial_slide25short-Vp watch editorial_slide25short-
Vp watch editorial_slide25short-
 
Vp watch2002
Vp watch2002Vp watch2002
Vp watch2002
 
Vp symposium31602
Vp symposium31602Vp symposium31602
Vp symposium31602
 
Vpschoenhagen
VpschoenhagenVpschoenhagen
Vpschoenhagen
 

Recently uploaded

Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
LEFLOT Jean-Louis
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
Dr. Ahana Haroon
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
AksshayaRajanbabu
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
NX Healthcare
 
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
Traumasoft LLC
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
FFragrant
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathologypathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
ZayedKhan38
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
anaghabharat01
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.
Gokuldas Hospital
 

Recently uploaded (20)

Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
 
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathologypathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.
 

Adeli 21 24